Mochi Health Lowered Prices for Compounded GLP-1s

The company has adjusted its pricing for weight loss medications and launched a new integrated blood-testing service.

Updated on Oct. 12, 2026 in Weight Loss

Mochi Health Lowered Prices for Compounded GLP-1s

Live Poll

Do you trust telehealth providers to manage specialized weight-loss medication treatments effectively?

Mochi Health has reduced the monthly cost of compounded semaglutide to $60 and compounded tirzepatide to $90. The company also introduced a $26 core health panel blood-testing service to support its weight management programs.

Why it matters

The company revised its pricing structure to better align medication costs with specific dosage levels. This shift impacts how patients manage expenses for ongoing weight loss support and monitoring through virtual care platforms.

The new pricing model includes compounded semaglutide starting at $60 and compounded tirzepatide at $90 per month, alongside $79 monthly membership fees. These compounded products are not FDA-approved, and the new laboratory services remain unavailable in New York, New Jersey, Rhode Island, and Hawaii.

The players

Mochi Health

A virtual care provider specializing in weight management and the prescription of GLP-1 medications.

The details

Patients gain access to these medications following a 30-minute virtual appointment with a licensed healthcare provider who evaluates their health needs. For blood testing, patients request the service through the Mochi portal and visit a participating lab location. The membership plan includes unlimited provider visits and direct messaging, designed to provide ongoing oversight as patients move through their weight loss journeys.

Timeline

  1. October 12, 2026

Health Landscape

The market for compounded GLP-1 medications remains distinct from the supply of FDA-approved counterparts, with pricing and availability fluctuating as services scale. This update follows a broader trend of virtual clinics integrating lab services directly into their care models.

If you are considering compounded medications, it is important to discuss the implications of using products that are not FDA-approved with your primary physician. Patients should also verify if laboratory testing services are available in their specific state before enrolling.

The takeaway

When navigating weight loss programs, prioritize services that offer transparent pricing and integrated medical oversight. Always ensure that your provider conducts a thorough review of your health history during the initial virtual consultation.

Further reading

Learn more about the latest developments in weight management in our Weight Loss section.

Source note: This article includes information reported by The Holland Sentinel Online.

Live Poll

Do you trust telehealth providers to manage specialized weight-loss medication treatments effectively?